| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0008 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |